See more : Vindicator Silver Lead Mining Co. (VINS) Income Statement Analysis – Financial Results
Complete financial analysis of ARISTO BIO-TECH AN (ARISTO-SM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ARISTO BIO-TECH AN, a leading company in the Chemicals industry within the Basic Materials sector.
- Eastern Treads Limited (EASTRED.BO) Income Statement Analysis – Financial Results
- Adavale Resources Limited (ADRLF) Income Statement Analysis – Financial Results
- Multibax Public Company Limited (MBAX.BK) Income Statement Analysis – Financial Results
- Dhanalaxmi Roto Spinners Limited (DHANROTO.BO) Income Statement Analysis – Financial Results
- Jupiter Wagons Limited (JWL.BO) Income Statement Analysis – Financial Results
ARISTO BIO-TECH AN (ARISTO-SM.NS)
Industry: Chemicals
Sector: Basic Materials
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 2.45B | 2.18B | 1.66B | 1.67B | 2.01B | 2.02B |
Cost of Revenue | 2.26B | 1.96B | 1.47B | 1.50B | 1.88B | 1.84B |
Gross Profit | 191.10M | 218.55M | 185.63M | 170.66M | 135.76M | 174.07M |
Gross Profit Ratio | 7.80% | 10.03% | 11.20% | 10.21% | 6.75% | 8.63% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 36.98M | 58.18M | 53.89M | 36.26M | 38.45M | 47.44M |
Selling & Marketing | 298.00K | 247.00K | 41.00K | 43.00K | 2.25M | 3.45M |
SG&A | 37.28M | 58.42M | 53.94M | 36.30M | 40.70M | 50.88M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 37.28M | 149.65M | 147.25M | 133.70M | 100.44M | 112.69M |
Cost & Expenses | 2.30B | 2.11B | 1.62B | 1.64B | 1.98B | 1.96B |
Interest Income | 16.94M | 21.51M | 18.58M | 21.98M | 21.36M | 20.36M |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 15.71M | 15.36M | 10.99M | 7.49M | 5.19M | 5.07M |
EBITDA | 85.65M | 87.95M | 52.33M | 43.44M | 45.08M | 68.19M |
EBITDA Ratio | 3.49% | 4.04% | 3.16% | 2.60% | 2.24% | 3.38% |
Operating Income | 153.83M | 72.58M | 41.34M | 35.95M | 39.89M | 63.12M |
Operating Income Ratio | 6.27% | 3.33% | 2.49% | 2.15% | 1.98% | 3.13% |
Total Other Income/Expenses | -99.75M | -25.19M | -21.54M | -20.97M | -25.93M | -22.10M |
Income Before Tax | 54.08M | 47.39M | 19.80M | 14.98M | 13.96M | 41.03M |
Income Before Tax Ratio | 2.21% | 2.18% | 1.19% | 0.90% | 0.69% | 2.03% |
Income Tax Expense | 15.12M | 11.77M | 5.47M | 4.22M | 3.89M | 12.74M |
Net Income | 38.96M | 35.62M | 14.34M | 10.76M | 10.07M | 28.28M |
Net Income Ratio | 1.59% | 1.64% | 0.86% | 0.64% | 0.50% | 1.40% |
EPS | 5.72 | 6.72 | 2.87 | 2.15 | 2.02 | 5.66 |
EPS Diluted | 5.72 | 6.72 | 2.87 | 2.15 | 2.02 | 5.66 |
Weighted Avg Shares Out | 6.81M | 5.30M | 5.00M | 5.00M | 5.00M | 5.00M |
Weighted Avg Shares Out (Dil) | 6.81M | 5.30M | 5.00M | 5.00M | 5.00M | 5.00M |
Source: https://incomestatements.info
Category: Stock Reports